Experimental Drug Deals Effectively with Prostate Cancer Cells

by Medindia Content Team on August 15, 2006 at 10:13 AM Drug News

Email

Print This Page

Comment

bookmark

Font : A-A+

Experimental Drug Deals Effectively with Prostate Cancer Cells

An experimental RNA-based drug acts by using genetic material called targeting RNA, to enter cancer cells, and another type, called silencing RNA , to stop the expression of a protein that keeps the cells alive, thereby destroying prostate cancer cells leaving normal cells unharmed.

The drug, developed at Duke University Medical Center, uses one type of genetic material, called In tests in mice with prostate cancer, the drug shrank the size of their tumors by half, while the tumors in control mice that did not receive the drug continued to grow, said study co-author Bruce Sullenger, Ph.D., director of Duke's Translational Research Institute and chief of the Division of Experimental Surgery.

The mice showed no side effects from the treatment, Sullenger said.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

Notify me when reply is posted
I agree to the terms and conditions

Related Links

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Prostate Cancer

Prostate Cancer

This cancer affects men over the age of 50 years and screening with rectal examination and PSA can help both in early detection and effective treatment

Prostate Cancer: Treatment Options

Prostate Cancer: Treatment Options

Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemotherapy, cryosurgery or biologic therapy.

More News on:

Drug Toxicity Prostate Cancer Cancer and Homeopathy Parkinsons Disease Surgical Treatment Trans-Urethral Resection of the Prostate Signature Drug Toxicity Prostate Cancer Facts Cancer Facts Cancer Prostate Cancer: Treatment Options

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Find a Doctor

What's New on Medindia

Exfoliative Dermatitis

Exfoliative Dermatitis

Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...

Alström Syndrome / Alström-Hallgren Syndrome

Alström Syndrome / Alström-Hallgren Syndrome

Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...

Sodium zirconium cyclosilicate - Drug Information

Sodium zirconium cyclosilicate - Drug Information

Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...

View All

News Category

Should Pharmacists Prescribe Drugs? Merging Different Anti-malarial Vaccines Could Cut Malaria Cases Methadone and Buprenorphine May Lower Mortality Risk After Nonfatal Opioid Overdose Aleglitazar may be Effective for the Treatment of Liver Cirrhosis No Difference in Malignancy Rates Seen Between Tocilizumab and TNFi in Patients With RA, Says Study

News Archive

Date:
Category:
Keyword:

RapidSSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2018

This site complies with the HONcode standard for trustworthy health information:
verify here.